Table 3.
Strategy | Main advantages | Main limitations | Highlighted applications | Examples with nanomedicine |
---|---|---|---|---|
Monolayer cell culture | Inexpensive | Cell-line derived: clonal selection | Initial nanomedicine biological characterization. | [67] |
Co-culture | Representation of different TME populations | Condition optimization for the growth of different cell lines | Cell type-targeted therapies | [69], [95] |
Spheroid | Representation of: Cell-cell interactions Cell-matrix interactions In vivo-like gradients (over 400 µm diameter) Do not require highly specialized techniques |
Cell line-derived: clonal selection Higher costs than monolayer culture |
Tumor penetration studies | [75], [94], [95] |
Organoid | Patient-derived Maintenance of intra- and inter- tumor heterogeneity |
High costs Complex establishment and maintenance compared to cell line-derived cultures |
Patient-tailored therapies | [87] |
Tumor-on-chip | Supports microfluidics | High complexity Specific expertise and materials required |
High-throughput screening | [98] |
Bioprinting | High spatial control | Specific expertise and materials required | Tissue and organ fabrication when patterning and precisely biologics placing is required | [103], [104] |
Tumor microenvironment: TME